Literature DB >> 6433395

Supersensitivity psychosis in schizophrenic patients after sudden clozapine withdrawal.

B Ekblom, K Eriksson, L H Lindström.   

Abstract

In two patients with chronic schizophrenia, who were on clozapine medication for more than 6 months, a sudden withdrawal of the drug resulted in a very pronounced deterioration of the psychosis within 24-48 h. The most prominent symptoms were auditory hallucinations and persecutory ideas and one patient tried to commit suicide. These observations are interpreted as supersensitivity psychoses induced by the very effective clozapine treatment.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6433395     DOI: 10.1007/bf00464798

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  6 in total

1.  Behavioral patterns related to dopamine neurotransmission: effect of acute and chronic antipsychotic drugs.

Authors:  U Ungerstedt; T Ljungberg
Journal:  Adv Biochem Psychopharmacol       Date:  1977

Review 2.  Overview: maintenance therapy in psychiatry: I. Schizophrenia.

Authors:  J M Davis
Journal:  Am J Psychiatry       Date:  1975-12       Impact factor: 18.112

Review 3.  Antipsychotic drug action: clinical, biochemical, and pharmacological evidence for site specificity of action.

Authors:  R L Borison; A Hitri; A J Blowers; B I Diamond
Journal:  Clin Neuropharmacol       Date:  1983-06       Impact factor: 1.592

4.  Neuroleptic-induced supersensitivity psychosis: clinical and pharmacologic characteristics.

Authors:  G Chouinard; B D Jones
Journal:  Am J Psychiatry       Date:  1980-01       Impact factor: 18.112

5.  Neuroleptic-induced hypersensitivity of striatal dopamine receptors in the rat as a model of tardive dyskinesias. Effects of clozapine, haloperidol, loxapine and chlorpromazine.

Authors:  A C Sayers; H R Bürki; W Ruch; H Asper
Journal:  Psychopharmacologia       Date:  1975

6.  Tardive dyskinesia: summary of a Task Force Report of the American Psychiatric Association. By the Task Force on Late Neurological Effects of Antipsychotic Drugs.

Authors: 
Journal:  Am J Psychiatry       Date:  1980-10       Impact factor: 18.112

  6 in total
  18 in total

Review 1.  Clinical profile of clozapine: adverse reactions and agranulocytosis.

Authors:  J A Lieberman; A Z Safferman
Journal:  Psychiatr Q       Date:  1992

Review 2.  Withdrawal symptoms and rebound syndromes associated with switching and discontinuing atypical antipsychotics: theoretical background and practical recommendations.

Authors:  Anja Cerovecki; Richard Musil; Ansgar Klimke; Florian Seemüller; Ekkehard Haen; Rebecca Schennach; Kai-Uwe Kühn; Hans-Peter Volz; Michael Riedel
Journal:  CNS Drugs       Date:  2013-07       Impact factor: 5.749

3.  Clozapine response trajectories and predictors of non-response in treatment-resistant schizophrenia: a chart review study.

Authors:  Parita Shah; Yusuke Iwata; Eric E Brown; Julia Kim; Marcos Sanches; Hiroyoshi Takeuchi; Shinichiro Nakajima; Margaret Hahn; Gary Remington; Philip Gerretsen; Ariel Graff-Guerrero
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2019-08-19       Impact factor: 5.270

4.  Rebound insomnia after abrupt clozapine withdrawal.

Authors:  J Staedt; G Stoppe; G Hajak; E Ruther
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1996       Impact factor: 5.270

5.  Supersensitivity and clozapine withdrawal.

Authors:  K Eklund
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

6.  Receptor binding of N-(methyl-11C) clozapine in the brain of rhesus monkey studied by positron emission tomography (PET).

Authors:  P Hartvig; S A Eckernäs; L Lindström; B Ekblom; U Bondesson; H Lundqvist; C Halldin; K Någren; B Långström
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

7.  Early relapse after sudden withdrawal or dose reduction of clozapine.

Authors:  A Perényi; E Kuncz; G Bagdy
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

8.  Tardive psychosis: does it exist?

Authors:  T Palmstierna; B Wistedt
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

9.  Relapse following clozapine withdrawal: effect of neuroleptic drugs and cyproheptadine.

Authors:  H Y Meltzer; M A Lee; R Ranjan; E A Mason; P A Cola
Journal:  Psychopharmacology (Berl)       Date:  1996-03       Impact factor: 4.530

Review 10.  Clozapine. A review of its pharmacological properties, and therapeutic use in schizophrenia.

Authors:  A Fitton; R C Heel
Journal:  Drugs       Date:  1990-11       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.